Ekso Bionics Holdings Inc has announced that SPC Nottwill has finished training its team of physiotherapists with the Ekso GT robotic exoskeleton, and has booked patients to learn how to walk again.
Freedom Designs has announced an addition to its NXT product line, the Freedom NXT Mini, Generation NEXT Mini tilt-in-space wheelchair, built to accommodate developing infants and toddlers who require tilt-in-space mobility and appropriate customized adaptive seating.
In a recent news release, provider of technologies designed to analyze gait, foot function, sway, and biomechanics, Tekscan Inc, has announced that it will be showcasing a variety of its technology solutions at the 7th World Congress of Biomechanics meeting in Boston, July 6 to 11.
According to a recent study, using Smart Bed Technology to encourage compliance to patient positioning protocols had a key impact on the reduction and prevention of pressure ulcers among residents of long-term care centers.
Lingraphica, The Aphasia Company, recently spotlighted the availability of an iPad app component for its TalkPath Therapy, a cloud-based speech therapy solution for adults with aphasia.
Butler Mobility Products reports that it was recently recertified for its Inclined Platform Lift power unit.
A company news release announces that BMS Practice Solutions will be exhibiting the latest release of its RevFlow technology at the American Physical Therapy Association (APTA) NEXT Conference & Exhibition, held June 11 to 14 in Charlotte, NC.
A True Blue Tribune news story reports that NeuroTrax has announced the global availability of BrainCare, a cognitive assessment and report solution engineered to assist clinicians in advancing brain wellness of stroke survivors and traumatic brain injury (TBI) patients.
Students and graduates at the Victoria University of Wellington have reportedly engineered a balance board designed to encourage individuals undergoing physical therapy to keep motivated and to have fun.
Recent data has reportedly demonstrated the ability of the Precision Spectra spinal cord stimulator (SCS), marketed by Boston Scientific Corporation, to sustain “highly significant” low back pain relief 6 months following implantation.